Delivery Order SPE2DB20D3103-SPE2DB21FP7T8

Award Date 8/5/21
Potential Completion Date 8/6/21
Potential Value $2.4K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,849.01 firm fixed-price delivery order is for the supply of ANUCORT-HC 25 MG SUPPOSITORY 12S, a medical product. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,517.48, is for the delivery of 4559623852 - ANUCORT-HC 25 MG SUPPOSITORY 24S to support military healthcare programs. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical....
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,028.09 firm-fixed-price delivery order is for the supply of ANUCORT-HC 25 MG SUPPOSITORY 24S, a medical product. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive...
This federal contract award, valued at $27,314.21, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of ANUCORT-HC 25 MG SUPPOSITORY 24S, a medical product. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award, valued at $3,532.65, is for the delivery of ANUCORT-HC 25 MG SUPPOSITORY 12S, a pharmaceutical product. This is a Firm Fixed Price Delivery Order contract with a completion date of May 11, 2023. The contract was awarded on May 10, 2023, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a $6,084.26 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ANUCORT-HC 25 MG SUPPOSITORY 12S, a medical product, with a period of performance through April 2, 2025. This delivery order is issued under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award for $2,047.52 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of ANUCORT-HC 25 MG SUPPOSITORY 12S. The contract has an ultimate completion date of February 3, 2023 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit organization. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,085.73 firm fixed-price contract is for the supply of 4560286053 ANUCORT-HC 25 MG SUPPOSITORY 12S, a pharmaceutical product. The award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle...
This contract award, valued at $1,037.13, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of ANUCORT-HC 25 MG SUPPOSITORY 24S, a medical product, with an ultimate completion date of January 28, 2025. The contract is a Delivery Order under a Firm Fixed Price arrangement, with no set-aside designation indicated. Amerisourcebergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,409.30 delivery order (SPE2DX15D2213|SPE2DX24F7Y5K) is for the supply of ANUCORT-HC 25 MG SUPPOSITORY 12S, a pharmaceutical product. The contract has a completion date of December 28, 2023 and uses a Firm Fixed Price pricing type. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB21FP7T8
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,386.16 firm-fixed-price delivery order is for the supply of ANUCORT-HC 25 MG SUPPOSITORY 12S, a medical product.

The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. This IDC, which runs through November 2026, enables the DLA to efficiently procure essential medications and medical commodities across multiple therapeutic areas. The contract award did not have a set-aside designation, indicating open competition.

Generated 2/27/25, 11:14 AM